메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
저널정보
대한생화학·분자생물학회 BMB Reports BMB Reports 제52권 제1호
발행연도
2019.1
수록면
1 - 2 (2page)

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Cellular senescence is a state of permanent cell cycle arrest which exhibits large and flattened morphological characteristics. Cellular senescence might evolve to a beneficial process to suppress the accumulation of severely damaged cells. However, senescent cells are considered as the cause of age-related pathologies and diseases. In contrast to replicative senescence, premature senescence could be rapidly induced through intrinsic and extrinsic insults. Cancer cell senescence has been accepted as an alternative and attractive tumor suppressive mechanism. In addition to the non-proliferative aspect, senescence associated with diverse functionality affects tissue homeostasis through the communication with their neighboring cells. Aging is a time-dependent process of deterioration, accompanied by progressive metabolic alteration and accumulation of senescent cells. Thus, aging is the main risk factor for many chronic diseases. Chronic inflammation which is principally induced by senescence associated secretory phenotype (SASP) might be the major underlying cause of many age-related disease. Recently, senotherapeutics, medicines targeting to kill or modulate senescent cells selectively, have been implicated to be novel strategy for aging intervention which is applicable to promote healthy aging and to prevent or treat age-related diseases. This special issue invites one perspective and ten mini-reviews covering various senescence features, gene expression characteristics with aging, therapeutic strategies related with cancer and age-related diseases.

목차

등록된 정보가 없습니다.

참고문헌 (0)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0